IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.008
NA - Nord America 1.420
EU - Europa 605
SA - Sud America 261
AF - Africa 25
OC - Oceania 13
AN - Antartide 1
Totale 8.333
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.492
US - Stati Uniti d'America 1.340
CN - Cina 728
HK - Hong Kong 519
BR - Brasile 191
IT - Italia 170
GB - Regno Unito 131
VN - Vietnam 126
DE - Germania 81
CA - Canada 45
IN - India 45
NL - Olanda 39
AR - Argentina 35
MX - Messico 25
FI - Finlandia 24
CZ - Repubblica Ceca 20
FR - Francia 20
JP - Giappone 20
ID - Indonesia 19
TR - Turchia 18
RU - Federazione Russa 15
ES - Italia 14
ZA - Sudafrica 14
PL - Polonia 13
UA - Ucraina 13
AU - Australia 12
SE - Svezia 12
AT - Austria 10
BD - Bangladesh 10
EC - Ecuador 10
EE - Estonia 9
KR - Corea 7
CL - Cile 5
CO - Colombia 5
LT - Lituania 5
PY - Paraguay 5
VE - Venezuela 5
RO - Romania 4
SA - Arabia Saudita 4
BE - Belgio 3
DK - Danimarca 3
GR - Grecia 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MS - Montserrat 1
MW - Malawi 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
SI - Slovenia 1
TH - Thailandia 1
TO - Tonga 1
TW - Taiwan 1
YE - Yemen 1
Totale 8.333
Salva come PNG Salva come JPEG
Città #
Hong Kong 518
Singapore 463
Hefei 330
Ashburn 310
Dallas 227
Boardman 172
Beijing 157
London 116
Shanghai 113
Los Angeles 58
Ho Chi Minh City 45
Munich 40
Rome 40
San Francisco 40
Council Bluffs 26
Amsterdam 25
Hanoi 25
Santa Clara 25
New York 24
Pune 24
São Paulo 23
Toronto 21
Brooklyn 20
Brno 19
Mexico City 18
Seattle 17
Redmond 16
Montreal 15
Helsinki 14
Washington 14
Chicago 12
Haiphong 10
Stockholm 10
Tokyo 10
Turku 10
Warsaw 10
Xi'an 9
Boston 8
Milan 8
Ankara 7
Biên Hòa 7
Canberra 6
Johannesburg 6
Charlotte 5
Chennai 5
Denver 5
Hyderabad 5
Las Vegas 5
Melbourne 5
Naples 5
Paris 5
Phoenix 5
Yeonsu-gu 5
Atlanta 4
Bauru 4
Buenos Aires 4
Campinas 4
Curitiba 4
Ha Long 4
Miami 4
New Delhi 4
Ninh Bình 4
Oklahoma City 4
Padova 4
Ribeirão Preto 4
Rio de Janeiro 4
Riyadh 4
Sona 4
Vienna 4
West Jordan 4
Asunción 3
Athens 3
Camaçari 3
Capaccio 3
Copenhagen 3
Durham 3
Manchester 3
Montesilvano Marina 3
Moscow 3
Ningbo 3
Pescara 3
Porto 3
Porto Alegre 3
Quito 3
Tashkent 3
Anyang 2
Astana 2
Baku 2
Belo Horizonte 2
Boca Raton 2
Buffalo 2
Bắc Giang 2
Caluire-et-Cuire 2
Campina Grande 2
Cape Town 2
Catanduva 2
Catania 2
Caxias do Sul 2
Charleston 2
Contagem 2
Totale 3.261
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 251
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 229
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 220
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 212
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 212
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 211
Designing a broad-spectrum integrative approach for cancer prevention and treatment 210
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 204
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 198
Premetastatic niche: ready for new therapeutic interventions? 197
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 174
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 173
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 128
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 126
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 118
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 116
Anterior and posterior vaginal myomectomy: A new surgical technique 107
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 107
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 105
Biological effects of cabozantinib on bone microenvironment 102
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 98
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 98
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 97
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 95
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 95
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 95
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 95
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 95
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 94
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 94
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 93
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 93
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 93
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 90
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 90
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 89
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 88
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 68
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 62
Molecular prognostic factors in patients with pancreatic cancer 53
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 51
New targets, new drugs for metastatic bone pain: a new philosophy 51
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 49
MicroRNAs and bone metastasis: a new challenge 43
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 40
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 40
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 40
Denosumab for cancer-related bone loss 38
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis 37
New Technologies to Study the Interplay between Cancer Stem Cells and the Immune System 37
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence 36
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 36
Network approach in liquidomics landscape 36
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 35
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs) 35
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 35
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 34
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 33
Epidemiologia e caratteristiche delle metastasi ossee 33
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 32
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 32
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 32
Targeting bone metastases starting from the preneoplastic niche: home sweet home 31
CETUXIMAB: From bench to bedside 31
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 30
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 30
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 30
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. 30
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 30
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 30
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 30
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation 30
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 29
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 29
Oncologia 29
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 29
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 29
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 28
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 28
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 28
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 28
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 28
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 28
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 27
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 27
Bone Health in Cancer Patients 27
The role of bone microenvironment, vitamin D and calcium 27
Monoclonal antibodies 27
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 27
TUMORI NEUROENDOCRINI 26
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 26
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 26
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 26
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 25
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 25
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 25
Emerging Therapeutic Targets in Osteoncology 25
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 25
Emerging drugs for the treatment of bone metastasis 25
Facing SARS-CoV-2 outbreak in immunotherapy era 25
Totale 7.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20255.748 76 92 206 49 39 137 115 31 491 456 1.794 2.262
2025/20261.822 484 226 397 511 204 0 0 0 0 0 0 0
Totale 8.469